UK: Funding For Second Kymriah Indication After Talks And Price Cut

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

UK HTA body NICE says a second indication for Novartis’s groundbreaking CAR-T cell therapy Kymriah should be covered under the Cancer Drugs Fund.

Hands
NICE Said Yes To Kymriah Following Price Cut And Collaboration

After initially saying no, UK health technology appraisal body NICE now recommends Novartis’s groundbreaking CAR-T cell therapy Kymriah (tisagenlecleucel) for use within the Cancer Drugs Fund for treating relapsed or refractory diffuse large B-cell lymphoma in adults. The decision, hailed as a “step forward for personalised medicine,” comes after NHS England and Novartis struck a new commercial agreement offering a lower price than was originally tabled.

NICE published its final appraisal document on Kymriah in adults with r/r DLBCL on Feb. 1. It said the CAR...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography